|
TFE3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.407460E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.46440000000781E-05 |
| Normal-vs-Stage2 |
9.442300E-03 |
| Normal-vs-Stage3 |
3.628000E-02 |
| Normal-vs-Stage4 |
2.519800E-02 |
| Stage1-vs-Stage2 |
6.867400E-01 |
| Stage1-vs-Stage3 |
1.268550E-01 |
| Stage1-vs-Stage4 |
3.107200E-01 |
| Stage2-vs-Stage3 |
2.141400E-01 |
| Stage2-vs-Stage4 |
3.401600E-01 |
| Stage3-vs-Stage4 |
7.499600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.829600E-04 |
| Normal-vs-AfricanAmerican |
3.381100E-04 |
| Normal-vs-Asian |
1.259880E-03 |
| Caucasian-vs-AfricanAmerican |
7.903500E-03 |
| Caucasian-vs-Asian |
1.731800E-01 |
| AfricanAmerican-vs-Asian |
2.007400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.299200E-03 |
| Normal-vs-Female |
1.798850E-04 |
| Male-vs-Female |
8.069800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.013700E-04 |
| Normal-vs-Age(41-60Yrs) |
2.768100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.639230E-01 |
| Normal-vs-Age(81-100Yrs) |
5.183600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.060200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.691850E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.460400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.699800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.162600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.488800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.417060E-04 |
| Classical-VS-Follicular |
1.147840E-02 |
| Classical-VS-Other |
9.762000E-02 |
| Classical-VS-Normal |
7.50200000010359E-07 |
| Tall-VS-Follicular |
2.920600E-01 |
| Tall-VS-Other |
9.148400E-01 |
| Tall-VS-Normal |
8.406400E-01 |
| Follicular-VS-Other |
6.251800E-01 |
| Follicular-VS-Normal |
1.794580E-01 |
| Other-VS-Normal |
9.948000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.218140E-03 |
| Normal-vs-N1 |
1.872620E-01 |
| N0-vs-N1 |
2.905800E-01 |
|
|
